# Apertus Pharmaceuticals – FDA Inspection, Jan 16, 2020

Source: https://www.keypedia.com/records/fda_inspections/apertus-pharmaceuticals/69ebf067-fc54-434c-b431-ecc838356afd
Source feed: FDA_Inspections

> FDA inspection 1119160 of Apertus Pharmaceuticals, January 16, 2020. Classification: Voluntary Action Indicated (VAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1119160
- Company Name: Apertus Pharmaceuticals
- Inspection Date: 2020-01-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1293102 - 2025-10-31](https://www.keypedia.com/records/fda_inspections/apertus-pharmaceuticals/d2159b71-ad5c-474a-a568-a403b00cb157)

Company: https://www.keypedia.com/companies/apertus-pharmaceuticals/7436af25-9f52-43d1-a68e-002922496155

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
